CIK 0001625297
- Large accelerated filer
Supernus, Inc.
Sign in to watch- Ticker
- SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412520873
- Phone
- +1 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 10,430 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,843 shares (to pay taxes)
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale
- 4 Open-market buy Director bought 8 shares at $31.09 ($249)
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market buy Director bought 940 shares at $31.87 ($29,953)
- 4 Open-market buy Director bought 31 shares at $32.56 ($1,009)
Page 4 of 29 · 572 filings